EFFECT OF PIOGLITAZONE ON SERUM HIGH DENSITY LIPOPROTEIN (HDL) LEVELS OF TYPE-2 DIABETICS

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pakistan Armed Forces Medical Journal

• Publication date

  2016-04-30

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of Patterns of Lipid Profile in Type-2 Diabetics and Non- Diabetics

  2021cited by this paper
• Comparison of dyslipidemias in controlled & uncontrolled type ii diabetics

  2016cited by this paper
• Pioglitazone for diabetes prevention in impaired glucose tolerance.

  2011cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes

  2007cited by this paper
• Effects of pioglitazone hydrochloride on Japanese patients with type 2 diabetes mellitus.

  2007cited by this paper
• Dual PPAR α/γ Agonists: Promises and Pitfalls in Type 2 Diabetes

  2007cited by this paper
• Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)

  2007cited by this paper
• The cardiovascular effects of the thiazolidinediones: a review of the clinical data.

  2007cited by this paper
• Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk.

  2007cited by this paper
• PPARγ and human metabolic disease

  2006cited by this paper
• PPAR gamma and human metabolic disease.

  2006cited by this paper
• Effects of pioglitazone in familial combined hyperlipidaemia

  2006cited by this paper
• Effects of Angiotensin Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease: The Prevention of Events With Angiotensin Converting Enzyme Inhibition (PEACE) Trial: The PEACE Study Investigators

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Correlation between cardiovascular disease and diabetes mellitus: current concepts.

  2004cited by this paper
• Frequency of chronic complications of type II diabetes.

  2004cited by this paper
• Comparison of Mechanism and Functional Effects of Magnesium and Statin Pharmaceuticals

  2004cited by this paper
• Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

  2000cited by this paper

• No citing papers are available for this paper.